摘要
目的探讨舒利迭治疗稳定期慢性阻塞性肺疾病疗效观察。方法选择2009年5月～2012年5月在我院治疗的稳定期慢性阻塞性肺疾病患者64例为研究对象,随机分为研究组和对照组各32例。研究组在常规治疗的基础上加用舒利迭治疗,对照组仅给予常规治疗。比较两组的临床疗效。结果两组治疗后各项肺功能指标及临床症状评分均较治疗前有明显好转,差异有统计学意义(P<0.05或P<0.01);治疗后两组间比较,研究组显著优于对照组,差异有统计学意义(P<0.05)。结论舒利迭治疗稳定期慢性阻塞性肺疾病,可以改善患者的肺功能,缓解临床症状和体征。
Objective To discuss the clinical effect of Seretide in treatment of stable chronic obstructive pulmonary dis- ease. Methods Selected 64 cases with stable chronic？obstructive pulmonary disease from May 2009 to May 2012 were divided into study group and control group. Study group was treated by Seretide based on regular treatment. The clinical effects of two groups were compared. Results Index of pulmonary function and clinical symptom scores in two groups after treatment were better than before treatment（P 〈 0.05or P 〈 0.01 ）, and which in study group were better than control group after treatment （P 〈 0.05）. Conclusion Seretide in treatment of stable chronic obstructive pulmonary disease can improve pulmonary function, relieve various symptoms and sgns.
出处
《中国现代医生》
2012年第27期146-147,共2页
China Modern Doctor
关键词
慢性阻塞性肺疾病
舒利迭
肺功能
FEV1
Chronic obstructive pulmonary disease
Seretide
Pulmonary function
FEV1
